Early studies indicated that the androgen receptor (AR) could promote renal cell carcinoma (RCC) development and metastasis, but its linkage to RCC progression under hypoxia, remains unclear. The gene discussed is AR; the disease is hereditary clear cell renal cell carcinoma.